A Stem Cell-Based Therapy for Retinitis Pigmentosa

2/20/2015; 31 minutes

Retinitis pigmentosa (RP) is a genetic disease that gradually destroys the light sensing nerve cells, called photoreceptors, located in the retina at the back of the eye. UC Irvine professor Henry Klassen describes a CIRM-funded project that aims to begin a stem cell-based clinical trial for RP in early 2015. Rosalinda and German Barrero also speak about the devastating impact of RP on their lives and their excitement about the trial. (#29233)

Links & Resources

More Programs With

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2020 Regents of the University of California. All right reserved. Terms and Conditions of Use.